Loading...

EVOFEM BIOSCIENCES INC Earnings Reports 8-K Filing

VFM

EVOFEM BIOSCIENCES INC

()

2025 8-K

Distributorship Agreement

Securities Agreement Update

Agreement Termination

2025 Financial Results

Corporate Presentation Update

Annual Meeting Results

Financial Results Report

Merger Termination

Securities Purchase Amendment

Financial Results Report

Equity Offerings

Licensing Agreement

Financial Statements

Securities Agreement

License Agreement

Financial Results

External Links:

On May 15, 2025, Evofem Biosciences, Inc. released its financial results for the first quarter of 2025, highlighting key performance metrics. The filing includes details about ongoing operations as indicated in its press release.

AI Assistant

EVOFEM BIOSCIENCES INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.